SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058427
Filing Date
2023-11-03
Accepted
2023-11-02 18:15:10
Documents
76
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rare-20230930.htm   iXBRL 10-Q 3399890
2 EX-31.1 rare-ex31_1.htm EX-31.1 17386
3 EX-31.2 rare-ex31_2.htm EX-31.2 16910
4 EX-32.1 rare-ex32_1.htm EX-32.1 12958
5 GRAPHIC img215930992_0.jpg GRAPHIC 164196
  Complete submission text file 0000950170-23-058427.txt   11000594

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rare-20230930_cal.xml EX-101.CAL 49388
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20230930_lab.xml EX-101.LAB 441739
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rare-20230930_def.xml EX-101.DEF 199584
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20230930.xsd EX-101.SCH 67463
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20230930_pre.xml EX-101.PRE 328254
70 EXTRACTED XBRL INSTANCE DOCUMENT rare-20230930_htm.xml XML 2029486
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 231373923
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences